Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke
Clinical trial NCT04734548 · COMPLETED
Trial details
- NCT number
- NCT04734548
- Sponsor
- aptaTargets S.L.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-28
- Primary completion
- 2022-07-25
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.